Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 788Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
  Feedback 
  Subscribe 
 Back To Article

  Reader Comments

Year : 2021 | Volume:  12 | Issue Number:  2

ORIGINAL ARTICLE

Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients

Vyas Bhavya H, Darji Nishita H, Rana Devang A, Vyas Kaushal Y, Malhotra Supriya D

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

 

 
Sitemap | What's New Feedback | Copyright and Disclaimer | Privacy Notice
© Perspectives in Clinical Research | Published by Wolters Kluwer - Medknow
Online since 20th October, 2010